The test of production of the 198 Au radioisotope by means of Varian medical linear accelerators used in teleradiotherapy was carried out. The targets made of the natural gold (100% of the 197 Au isotope) were irradiated with high-energy therapeutic 20 MV X-ray beam.
Introduction
The characteristics of 198 Au -beta emission of 0.96 MeV (98.6%) and 0.412 MeV (95.5%) of gamma radiation [1] -opens many interesting therapeutic possibilities. In fact, 198 Au has been widely used to treat the uterus, bladder, cervix, prostate, melanoma, breast, skin and other cancers. The 198 Au radioisotope with a high specific activity can be easily produced in the simple capture reaction 197 Au(n, γ) 198 Au in a nuclear reactor [1] . However, in this work, its production with medical linear accelerators is considered. In our previous paper [1] , we demonstrated the technical aspects of the 99 Mo/ 99m Tc complex production with the use of medical liniacs. In the current work, the 20 MV X-ray therapeutic beam generated by the Clinac TrueBeam linac installed at the Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology in Gliwice (Poland) was applied. Such high-energy photon therapeutic beams induce photonuclear reactions (γ, n) in which neutrons are emitted with a wide spectrum of energies [2] [3] [4] [5] . The X-ray beam energy and the produced slowed down neutron fluence are found to be correlated [6] [7] [8] . The photonuclear cross section has a resonance character. Its maximum value depends on an atomic number and it is in the range from several millibarns for light nuclei to several hundred millibarns for heavy nuclei. Moreover, the maximum photonuclear cross section corresponds to gamma energy of about 22 MeV for light nuclei and about 12 MeV as the atomic number increases. The energy threshold of the photonuclear reactions is about 8 MeV for most isotopes.
Materials and methods
The only stable natural gold isotope 197 Au was used as a target material for activation. The gold targets of the 0.5 cm × 0.5 cm × 0.1 mm were mounted on the accelerator window within the therapeutic 20 MV X-ray beam path as well as on the walls of the treatment room. In such locations the gold target is in the neutron field produced during 20 MV X-ray beam emission. The slowed down neutron fluence in the TrueBeam linac accelerator room is almost constant, as reveals from our earlier studies [8] . The cross section of the 197 Au(n, γ) 198 Au reaction equals 98.5 barn for thermal neutrons [9] . Moreover, this reaction is characterized by the high resonance
TABLE I
The obtained specific activities of the gold targets in the saturation state A s with the percentage uncertainties below 1% for various irradiation conditions (ic, the first column). Irradiation fields were determined in a horizontal plane perpendicular to the main axis of the used therapeutic 20 MV X-ray beam at 100 cm from the middle of the target converting electrons into X-rays. of 32900 barns at 4.9 eV and several smaller resonances in the epithermal energy range. The resonance activation integral is 1558 barns [10] . The activities of the activated targets were determined from the gamma-ray decay spectra of the produced radioisotope 198 Au. The spectra were acquired using two Ge(Li) semiconductor detectors. The energy and efficiency calibration of these detectors was carried out with the use of the commercial sources of 152 Eu and 133 Ba. The activation of the gold targets was performed for various irradiation conditions (Table I) . In one case, the irradiation conditions were modified by adding a system consisting of 5 cm × 5 cm × 5 cm blocks of lead located on the PMMA phantom. In such set, lead was an additional source of neutrons, whereas the PMMA material acted as a neutron moderator.
Results and discussion
The exemplary spectra of 198 Au radioisotope decay are presented in figure 1. In the case of the outside beam target activation, a peak at 411.8 keV dominates in the spectrum ( Fig. 1 (a) ), whereas for the targets activated inside the beam the decay lines seen at 333.0 keV, 355.7 keV and 426.1 keV correspond to the photons emitted in the decay of 196 Au, which itself originates from the photonuclear reaction 197 Au(γ, n) 196 Au ( Fig. 1 (b) ). The properties of this radionuclide -its decay photon energies as well as its halflive T 1/2 = 6.183 d -make it very interesting for use in nuclear medicine. Unfortunately, at present, 196 Au has not been discovered for medical use yet. We plan to describe the details of the 196 Au production by means of a high-energy therapeutic beam from a medical linac in our future paper. The saturation specific activities obtained under various irradiation conditions differ markedly (Table I ). In general, the activities of gold targets are greater for the inside-beam activation and for the small radiation filed. Application of the lead-PMMA system increasing a slowed down neutron field led to higher activities. The saturation curve for the case with the obtained maximum saturation activity is shown in figure 2 . Due to a relatively long half-live of 198 Au decay (T 1/2 = 2.695 d), the time needed for reaching the activity saturation -of about 400 hours -is too long from the practical point of view. Thus, it is necessary to increase a slowed down neutron field significantly. It can be achieved by the appropriate optimization of a configuration of the lead-PMMA shielding blocks placed inside the beam. 
Conclusions
The maximum activity of 198 Au generated during operation of medical linear accelerators is too low for this radioisotope to be used in nuclear medicine applications. However, the produced amount of 198 Au is sufficient to make use of this radionuclide in laboratory tests of new drugs for potential clinical applications. Moreover, the 198 Au activity can be easy increased, if necessary, by increasing a neutron production in photonuclear reactions induced by a therapeutic X-ray beam.
